Cantor Fitzgerald Reiterates “Overweight” Rating for Acrivon Therapeutics (NASDAQ:ACRV)
Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report)‘s stock had its “overweight” rating reissued by stock analysts at Cantor Fitzgerald in a report issued on Wednesday,Benzinga reports. A number of other brokerages have also weighed in on ACRV. HC Wainwright cut their price target on shares of Acrivon Therapeutics from $22.00 to $19.00 and set a […]
More Stories
A New Food Pyramid for a Metabolically Unwell Nation
By Sherami Tsai With chronic illnesses soaring across the United States, a group of doctors and nutrition researchers say it’s...
Goods at Sea Dodge Tariffs Until May, Those Warehoused Taxed When Taken
By John Haughey With a whirlwind of changes to U.S. tariffs, there’s a scramble to understand how the duties will...
OpenAI Countersues Musk Over Alleged Harassment
By Naveen Athrappully OpenAI is suing Elon Musk, accusing the tech billionaire of engaging in a harassment campaign against the...
Consumer Spending Holds Firm Amid Tariff Pressures, Bank of America Finds
By Tom Ozimek U.S. consumer spending continued to show resilience in March, bolstered by higher-income households and targeted spending ahead...
House Passes Bill to Require Proof of Citizenship to Vote
By Joseph Lord and Jackson Richman The House on April 10 gave the nod to a bill that would enhance...
Six Die After Helicopter Crashes in the Hudson River Near Manhattan
By Jacob Burg A helicopter crashed into the Hudson River just off Manhattan on April 10, killing all six on...